Skip to content

Opioid Crisis Grants 2026: SOR, RCORP, DFC

Updated 10 official sources

Quick Answer: Opioid crisis grants from federal agencies are spread across SAMHSA, HRSA, CDC, ONDCP, and DOJ programs.

Full answer and how we checked it

This guide is for treatment providers, prevention coalitions, recovery organizations, rural health networks, public health departments, and local governments seeking opioid crisis grants in 2026. The State Opioid Response (SOR) grant ($1.5 billion+) is the largest single program, flowing to every state. RCORP targets rural communities (its FY2026 Planning and Impact deadlines passed July 8, 2026). Drug-Free Communities funds local prevention coalitions. Additional programs support MAT expansion, naloxone distribution, overdose surveillance, and recovery housing. Opioid litigation settlement funds add billions more, though those follow separate rules.

Data note: SOR figures come from SAMHSA's FY2025 continuation announcement. RCORP and MAT-PDOA figures come from the FY2026 notices on Grants.gov. Amounts marked "see agency budget" weren't confirmed at source for this update. Grantsights checked the FY2026 RCORP and MAT-PDOA notices on Grants.gov (opens in a new tab) against this guide on October 9, 2026 and replaced older award ranges. A common mistake is applying with figures from an earlier cycle: RCORP-Planning awards fell to $100,000, and the FY2026 MAT-PDOA notice was open to public and private nonprofits, not only states.

In this guide

Find the foundations most likely to fund your organization

Type your organization's name. We'll show the foundations that fund groups like yours, from their own IRS filings, with the reasons for each. Free, no sign-up. See a sample

Foundations that fund this work

44,507 private foundations gave to hospitals, clinics, hospices and health charities

From their own IRS Form 990-PF filings (tax years 2019 to 2025). Pick your state to see who takes requests there, with three in full. About the list

Across the US, these foundations gave 296,132 grants totaling $49,431,675,215.

One payment

Health funder list

$29once

All 44,507 foundations, state by state.

  • Each grant's amount, recipient, year and purpose
  • Whether its filing says it takes requests
  • How to apply, and a CSV download

Historical giving does not establish an open application or eligibility for your organization. Running a business rather than a nonprofit? Most foundations fund only 501(c)(3) groups, so check each one's rules before buying.

If you don't find 5 foundations worth writing to, full refund within 30 days. Questions: team@grantsights.com.

Need every cause, with weekly filing alerts? Grantsights Pro is $199 a year, and a list you buy now counts toward it.

Foundation data from the foundations' own public tax returns (IRS Form 990-PF), not government grants. We never promise funding.

Other ways to buy

  • Paid by card through Stripe, with an emailed receipt (refund details in our terms).
  • For comparison, full foundation databases are subscriptions: Candid Premium is $1,199 a year (nonprofit price, billed annually) and Instrumentl starts at $299 a month (billed annually). This list is $29, once.
  • Questions before you buy? Email Erik Jia, who runs Grantsights, at team@grantsights.com.
Which best describes you?

Grant finder

Open grants and foundations that take requests for health care.

See the best fits for your organization, free for 14 days.

Start free

No card. Nothing is charged when it ends.

If you're a treatment provider, prevention coalition, recovery organization, health department, or community group working on the opioid crisis, this guide maps every major federal opioid crisis grants program in 2026. This is for clinical directors at opioid treatment programs, community coalition coordinators, rural health organizations, grant writers at behavioral health agencies, and public health officials managing local opioid response.

The federal response to the opioid crisis has created one of the largest disease-specific funding streams in U.S. history. But the money is scattered across at least six federal agencies, dozens of individual programs, and multiple funding mechanisms. Add opioid litigation settlement funds on top, and the picture gets even more complex.

The crisis itself has evolved. Fentanyl has replaced prescription opioids and heroin as the primary driver of overdose deaths. Polysubstance use involving stimulants alongside opioids has complicated treatment approaches. And the geographic burden has shifted from the initial Appalachian epicenter to a nationwide crisis affecting urban, suburban, and rural communities in every state.

The funding has adapted, though not always quickly. This guide covers where the money is in 2026 and how to access it.

According to SAMHSA, State and Tribal Opioid Response grants provided more than $1.5 billion in FY2025 continuation awards; see the agency's SOR funding announcement (opens in a new tab). According to HRSA, RCORP funds rural substance use disorder prevention, treatment, and recovery work through several grant programs; see the RCORP program page (opens in a new tab). According to CDC, Overdose Data to Action supports overdose surveillance and prevention work by state and local health departments; see CDC's overdose prevention hub (opens in a new tab). According to Grants.gov, each direct federal opportunity still carries its own applicant, match, and package rules.

Federal Opioid Funding: 8 Major Streams

ProgramAgencyAnnual FundingPrimary Recipients
State Opioid Response (SOR)SAMHSA$1.5 billion+States and territories
SABG (opioid-related portion)SAMHSASee agency budgetStates
RCORPHRSA~$200 millionRural communities
Drug-Free CommunitiesONDCP~$100 millionCommunity coalitions
Overdose Data to ActionCDCSee agency budgetStates and localities
HIDTAONDCPSee agency budgetRegional task forces
MAT-PDOA (FY2026)SAMHSA$68.25 millionPublic and private nonprofits
Opioid settlementsN/A (litigation)Multi-year payments; variesStates and localities

For broader context on SAMHSA's grant programs beyond opioid-specific funding, see our SAMHSA grant programs guide.


Best Fit and Bad Fit Checklist for Opioid Crisis Grants

Our analysis is that opioid funding works best when applicants stop treating "opioid response" as one category. Reviewers score treatment access, rural service networks, prevention coalitions, harm reduction, and settlement-funded capital needs differently.

Applicant situationBest routeBad fit signal
Licensed treatment provider expanding MAT or recovery supportState SOR subgrants, SAMHSA treatment grants, Medicaid alignmentNo plan for prescriber support, billing, or post-grant sustainability
Rural consortium with service gapsHRSA RCORP planning, implementation, or network grantsConsortium letters are vague or missing a treatment provider
Youth prevention coalitionDrug-Free Communities, state prevention set-aside fundsCoalition cannot document the 12 required sectors or local youth data
Health department improving surveillanceCDC OD2A or state overdose prevention fundingProposal is only data collection with no data-to-action plan
Local government with settlement fundsSettlement abatement plans layered with federal grantsFunds replace existing services rather than adding capacity

Example: a rural coalition with a hospital, behavioral health provider, county health department, and recovery nonprofit should usually start with RCORP planning or implementation, then seek state SOR subgrants for treatment slots and settlement funds for vans, outreach supplies, or workforce incentives. To compare active substance use and behavioral health opportunities, use the Grantsights grant database.


Get grant deadline alerts by email

About once a week, we email a short list of open grant calls with real deadlines from different funders. It isn't limited to the programs in this guide.

No spam. Unsubscribe anytime.

State Opioid Response (SOR) Grant

The SOR grant is the centerpiece of federal opioid response funding and the single largest program specifically targeting the opioid crisis.

How SOR Works

SAMHSA distributes SOR funds to all 50 states, territories, and Washington D.C. using a formula based on:

  • Unmet need for opioid use disorder treatment
  • Drug poisoning deaths

States receive their allocation and then design their own response strategies, subject to SAMHSA requirements.

SOR Required Activities

States must use SOR funds for:

  • Increasing access to FDA-approved medications for opioid use disorder (buprenorphine, methadone, naltrexone)
  • Naloxone distribution and overdose reversal training
  • Evidence-based prevention, treatment, and recovery support services

SAMHSA requires that states prioritize populations at highest risk, including individuals reentering communities from criminal justice involvement, homeless populations, and pregnant and postpartum women.

How Providers Access SOR Funds

Individual treatment providers, recovery organizations, and community health centers don't apply directly to SAMHSA for SOR funds. Instead:

  1. Your state's Single State Agency (SSA) for substance abuse receives the SOR allocation
  2. The SSA issues sub-grants, contracts, or direct services using SOR funds
  3. Providers apply to the state for SOR-funded opportunities

What SOR typically funds at the provider level:

  • MAT startup costs (training, licensing, initial medication supplies)
  • Peer recovery specialist positions
  • Mobile crisis and outreach teams
  • Recovery housing operations
  • Naloxone purchasing and distribution
  • Wrap-around services (transportation, childcare, employment support)

Contact your state SSA to find out what SOR-funded opportunities are currently available. Many states maintain a specific SOR page on their substance abuse agency website.

SOR Evolving in 2026

SOR has expanded beyond its original opioid-only focus. Recent iterations allow states to use a portion of funds for stimulant use disorder treatment, reflecting the reality that most opioid-involved overdose deaths now also involve stimulants. The program has also increased its emphasis on harm reduction services, including syringe service programs and fentanyl test strip distribution.


HRSA Rural Communities Opioid Response Program (RCORP)

RCORP is the federal government's primary investment in rural-specific opioid and substance use disorder response.

RCORP Structure

HRSA restructures RCORP tracks from year to year, so check the current notice. The FY2026 and FY2027 tracks on Grants.gov:

TrackFundingStatusPurpose
RCORP-Planning (HRSA-26-036)$100,000 awards; about 40 awards; $4M totalClosed July 8, 2026Build partnerships and starting capacity for SUD services
RCORP-Impact (HRSA-26-037)Up to $750,000; about 80 awards; $60M totalClosed July 8, 2026Expand prevention, treatment, and recovery services
RCORP Overdose Response (HRSA-27-040)See forecastFY2027 forecastOverdose response in rural communities
RCORP Community Systems Development (HRSA-27-042)See forecastFY2027 forecastRural SUD service systems
RCORP Evaluation (HRSA-27-041)See forecastFY2027 forecastProgram evaluation

Both FY2026 notices accepted domestic public or private, nonprofit or for-profit entities, according to Grants.gov (opens in a new tab).

RCORP Eligibility

RCORP Application Tips

RCORP reviewers prioritize:

  • Consortium strength. Real partnerships with shared governance, not just letters of support
  • Community data. Overdose death rates, treatment gap analysis, geographic access barriers
  • Sustainability planning. How you'll maintain services after the grant ends
  • Harm reduction inclusion. HRSA has increasingly expected RCORP applicants to include naloxone distribution and other harm reduction strategies

If you missed the July 8, 2026 deadlines, watch the FY2027 RCORP forecasts on Grants.gov (opens in a new tab). For more on rural health funding, see our guide on grants for healthcare organizations.

If the rural network still needs partner formation, needs assessment, and a shared service plan, use the HRSA RCORP-Planning guide before writing for implementation money.


Drug-Free Communities (DFC) Program

The DFC program, run by ONDCP (Office of National Drug Control Policy) in partnership with CDC, is the federal government's primary investment in community-based substance abuse prevention coalitions.

DFC Basics

  • Award: $125,000 per year
  • Duration: Up to 5 years (initial), renewable for 5 more years (up to 10 total)
  • Eligible applicants: Community coalitions with representation from 12 required sectors
  • Match: 100% non-federal match in Years 1 through 6, according to CDC's DFC FAQ (opens in a new tab)

The 12 Required Sectors

DFC coalitions must include representatives from:

  1. Youth
  2. Parents
  3. Business community
  4. Media
  5. School personnel
  6. Youth-serving organizations
  7. Law enforcement
  8. Religious/fraternal organizations
  9. Civic/volunteer groups
  10. Healthcare professionals
  11. State, local, or tribal government agency with expertise in the field of substance use
  12. Other organization involved in reducing substance use

Why DFC Matters for Opioid Prevention

DFC coalitions work upstream from treatment, implementing environmental strategies that reduce substance abuse at the community level. For opioid prevention, this includes:

  • Prescription drug take-back events and permanent collection sites
  • Community education on safe storage and disposal of medications
  • Youth prevention programming
  • Policy advocacy for prescribing guidelines
  • Community norms campaigns

DFC isn't opioid-specific, but many coalitions have shifted their focus to include opioid prevention alongside alcohol and other drug prevention.

Coalitions with past DFC funding should use the DFC Competing Continuation Year 6 guide before applying through the wrong DFC lane. Year 6 depends on prior DFC status, 12 sectors, and 100% non-federal match.

DFC Application Process

CDC's National Center for Injury Prevention and Control posts DFC funding opportunities on Grants.gov (opens in a new tab) (for example, CDC-RFA-CE21-210206CONT26 for the FY2026 Year 6 cycle). Applications are reviewed by peer panels, and awards are announced in the fall for funding beginning the following fiscal year.

What makes applications competitive:

  • Active coalition with documented meeting attendance across all 12 sectors
  • Community needs assessment with substance use data
  • Logic model connecting strategies to outcomes
  • Evidence-based prevention strategies (SAMHSA's evidence-based practices resource center)
  • Evaluation plan with measurable outcomes

MAT Expansion and Treatment Access Programs

SAMHSA MAT-Specific Grants

Several SAMHSA programs specifically target expanding medication-assisted treatment:

Medication-Assisted Treatment Prescription Drug and Opioid Addiction (MAT-PDOA):

  • The FY2026 notice (TI-26-008 (opens in a new tab)) was open to domestic public and private nonprofit entities, including faith-based organizations
  • Supports training, workforce development, and treatment infrastructure
  • FY2026 award ceiling $750,000, about 91 awards, $68.25 million total; applications closed July 27, 2026

Targeted Capacity Expansion: Medication Assisted Treatment (TCE-MAT):

  • Direct grants to treatment providers
  • Funds treatment slots, clinical staff, and support services
  • Supports integration of MAT into primary care, emergency departments, and criminal justice settings

Prescriber Training and Support

Federal funding supports training programs for prescribers:

  • PCSS (Provider Clinical Support System): SAMHSA-funded training and mentoring for providers delivering MAT
  • ECHO Model programs: HRSA and SAMHSA fund Project ECHO hubs that provide virtual mentoring and case consultation for MAT providers in rural and underserved areas

The Post-X-Waiver Era

Since the elimination of the X-waiver requirement for prescribing buprenorphine in 2023, any DEA-registered provider with a standard Schedule III prescription authority can prescribe buprenorphine for opioid use disorder. This policy change has expanded the pool of eligible prescribers but hasn't automatically increased treatment capacity. Federal grants now focus on supporting providers who are newly authorized to prescribe but lack the clinical training, support infrastructure, and confidence to start treating patients.


CDC Overdose Prevention Programs

Overdose Data to Action (OD2A)

CDC's primary opioid funding mechanism provides cooperative agreements to states and localities for:

  • Enhanced fatal and nonfatal overdose surveillance
  • Rapid data sharing between public health and public safety
  • Evidence-based prevention strategies
  • Linkage to care after nonfatal overdose events
  • Prescription drug monitoring program (PDMP) enhancement

Funding: Several hundred million dollars annually, with awards to all 50 states plus selected local jurisdictions.

CDC Harm Reduction Program

CDC funds harm reduction activities through several mechanisms:

  • Syringe services program support
  • Naloxone distribution
  • Fentanyl test strip distribution
  • Linkage to treatment and social services at harm reduction sites

HIDTA: High Intensity Drug Trafficking Areas

The HIDTA program, administered by ONDCP, funds multi-agency task forces that combine law enforcement with public health approaches:

  • Funding: Distributed across designated HIDTA regions nationwide; check ONDCP's HIDTA page for current figures
  • Activities: Drug interdiction, investigation, intelligence, and increasingly, treatment and prevention partnerships
  • Provider relevance: Some HIDTA regions fund treatment and recovery services as part of their public health strategy. Contact your local HIDTA to explore partnership opportunities.

Opioid Litigation Settlement Funds

While not federal grants, opioid settlement funds represent the largest new funding source for opioid response:

  • Total pool: Tens of billions of dollars from settlements with pharmaceutical manufacturers, distributors, and pharmacies
  • Distribution period: Multi-year payment schedules that vary by agreement
  • Allowable uses: Varies by settlement agreement, but generally includes treatment, prevention, harm reduction, recovery services, criminal justice programs, and some infrastructure

How Settlements Interact with Federal Grants

Settlement funds and federal grants can complement each other, but there are rules:

  • No supplanting. Settlement funds shouldn't replace existing federal or state funding
  • Different timelines. Federal grants have project periods; settlements have 15+ year payment schedules
  • Different oversight. Federal grants have extensive reporting; settlement oversight varies by state and settlement agreement
  • Strategic layering. Use federal grants for evidence-based program models and settlement funds for capital costs, workforce incentives, and activities that federal grants don't cover well

What SAMHSA's SOR Dashboard Won't Show You About Who Actually Gets the Money

The most consistent frustration isn't the program design. It's the information blackout between the state receiving its SOR allocation and a provider receiving a subgrant. SAMHSA distributed $1.48 billion in FY2025 SOR continuation funding to states, but public data on which subrecipients get the money afterward is thin. That means providers often can't find out which organizations in their state received SOR subgrants, in what amounts, or for what services. Calling your state's Single State Agency is the only way to get this information, and even then, staff turnover at state agencies means the person who answers may not know which RFPs are upcoming.

The abatement definition problem is more serious than national coverage suggests. Settlements with the major distributors (McKesson, Cardinal Health, AmerisourceBergen) require most funds to go to opioid abatement, but "abatement" was left broad. Watchdog reporting has described jurisdictions spending settlement dollars on items like law enforcement equipment with little documented connection to OUD treatment. National watchdog trackers like KFF Health News's "Payback" project and Johns Hopkins's Opioid Principles Dashboard track this spending publicly, and the data isn't flattering. For nonprofits seeking access to settlement funds, this matters because jurisdictions burning money on non-treatment activities are also the ones that don't have capacity to run competitive grant processes for service providers.

The RCORP program is genuinely valuable for rural organizations, but the consortium requirement can eliminate otherwise strong applicants. RCORP notices have typically asked for a multi-organization consortium with treatment capacity, so check the current notice for the exact requirement. In rural counties where there may be only one treatment provider, that provider may not have time to join a consortium. RCORP applications can collapse at the Letter of Commitment stage, so secure partner letters before you write the narrative.

SOR's stimulant use disorder expansion, which allowed states to use a portion of SOR IV funds for non-opioid stimulants like methamphetamine, hasn't translated into proportional increases in stimulant treatment capacity. Many states still direct the large majority of SOR dollars to MAT, naloxone, and opioid-specific services, while stimulant treatment, which has no FDA-approved medication, gets only a small slice despite stimulants now appearing in most opioid overdose deaths. If you're a provider with stimulant treatment capacity, specifically contingency management programs, your applications will stand out in a field where almost everyone is writing about buprenorphine.


What Federal Agencies Don't Tell You About Opioid Funding

The official program descriptions emphasize evidence-based treatment and recovery. Here's what they gloss over.

The money is enormous, but fragmentation reduces its impact. When you add up SOR, SABG, RCORP, DFC, CDC, HIDTA, settlement funds, and other sources, the total is large, but there's no single official figure. These dollars flow through different agencies, different mechanisms, and different timelines, making coordination at the local level extremely difficult. Many communities receive money from five or six sources, each with its own reporting requirements and allowable activities, creating an administrative burden that absorbs resources better spent on services.

Settlement funds are being used poorly in many jurisdictions. Without the federal oversight that accompanies grants, some state and local governments are spending opioid settlement funds on general government expenses, jail construction, or programs with little connection to substance use disorder treatment or prevention. Watchdog organizations are tracking this, but there's no federal enforcement mechanism.

The evidence base for prevention is weaker than funders acknowledge. Federal programs require "evidence-based" prevention strategies, but the evidence for most community-level prevention approaches is modest at best. The strongest evidence supports MAT for treatment and naloxone for overdose reversal. Prevention programs often rely on community-level logic models rather than rigorous controlled trials.

Rural communities face a fundamental capacity problem. RCORP and other rural programs provide funding, but rural communities often lack the treatment workforce, organizational infrastructure, and administrative capacity to effectively use the money. An RCORP-Impact award of up to $750,000 doesn't help much if you can't recruit a physician or counselor to your community. Workforce programs and treatment funding need to be pursued simultaneously.

Political dynamics still shape which approaches get funded. Despite scientific consensus supporting harm reduction and MAT, some state and local officials resist funding syringe services, naloxone distribution, or medication-based treatment. Organizations in politically conservative areas may find it harder to access certain SOR-funded activities, depending on their state's priorities.

For more on substance abuse grant programs beyond opioid-specific funding, see our grants for substance abuse programs guide.


Building an Opioid Funding Strategy

For Treatment Providers

  1. Contact your state SSA for SOR-funded treatment expansion opportunities
  2. Apply for SAMHSA MAT-specific competitive grants
  3. Explore RCORP if you serve rural communities
  4. Train providers through PCSS and Project ECHO programs
  5. Layer settlement funds for capital and workforce costs

For Prevention Coalitions

  1. Apply for Drug-Free Communities if you haven't already
  2. Access SABG prevention set-aside funds through your state
  3. Coordinate with local HIDTA for prevention partnerships
  4. Explore CDC overdose prevention funding through your state health department

For Recovery Organizations

  1. Access SOR-funded recovery support services through your state
  2. Apply for recovery housing grants from SAMHSA
  3. Build peer recovery specialist programs funded through state SOR allocations
  4. Explore settlement funds for recovery capital and infrastructure

Sources

  • SAMHSA State Opioid Response Grants: https://www.samhsa.gov/grants/grant-announcements/ti-23-012
  • SAMHSA MAT-PDOA FY2026 (TI-26-008): https://www.samhsa.gov/grants/grant-announcements/ti-26-008
  • Grants.gov RCORP-Impact FY2026 (HRSA-26-037): https://www.grants.gov/search-results-detail/362284
  • CDC DFC NOFO FAQ: https://www.cdc.gov/overdose-prevention/php/drug-free-communities/nofo-faq.html
  • HRSA RCORP: https://www.hrsa.gov/rural-health/rcorp
  • ONDCP Drug-Free Communities: https://www.whitehouse.gov/ondcp/information-resources/grant-programs/
  • CDC Overdose Prevention: https://www.cdc.gov/overdose-prevention/
  • ONDCP HIDTA Program: https://www.whitehouse.gov/ondcp/information-resources/grant-programs/
  • SAMHSA MAT Programs: https://www.samhsa.gov/medications-substance-use-disorders
  • SAMHSA Evidence-Based Practices Resource Center: https://www.samhsa.gov/resource-search/ebp

Frequently Asked Questions

How much federal funding is available for opioid crisis programs?

There's no single official total, because opioid funding is spread across SAMHSA, HRSA, CDC, ONDCP, and DOJ programs and block grants. The largest single source is the State Opioid Response (SOR) grant from SAMHSA, distributing over $1.5 billion per year to states and territories. HRSA's Rural Communities Opioid Response Program (RCORP) provides approximately $200 million annually. The Drug-Free Communities (DFC) program distributes about $100 million to local coalitions. CDC's Overdose Data to Action program provides several hundred million to states for surveillance and prevention. These federal grants are supplemented by billions in opioid litigation settlement funds flowing to states and localities, though those aren't federal grants and have their own distribution rules.

What is the State Opioid Response grant and who can access it?

The State Opioid Response (SOR) grant is SAMHSA's largest opioid-specific program, distributing over $1.5 billion annually to all 50 states, territories, and Washington D.C. through a formula-based allocation. SOR funds go to the Single State Agency (SSA) for substance abuse, not to individual providers. States use SOR money for medication-assisted treatment (MAT) expansion, naloxone distribution, peer recovery support, workforce training, and other evidence-based interventions. Individual providers access SOR funding through their state's sub-grant process. Contact your state SSA to learn about available SOR-funded contracts, training opportunities, and MAT expansion support.

Can small community organizations get opioid grants, or is it mostly for states and large providers?

Several federal programs specifically target small community organizations. Drug-Free Communities (DFC) grants award up to $125,000 per year directly to community coalitions that meet CDC's 10 statutory eligibility requirements, including 12-sector representation and a 100% non-federal match. HRSA's RCORP-Planning and RCORP-Impact grants target rural organizations and consortia. Some SOR-funded sub-grants from states are also sized for small community providers. The challenge for small organizations isn't that grants don't exist; it's that the application processes require grant writing capacity that many small organizations lack.

What is RCORP and how does it help rural communities?

HRSA's Rural Communities Opioid Response Program (RCORP) provides funding specifically for rural communities addressing substance use disorders. In FY2026, HRSA ran two main tracks: RCORP-Planning (HRSA-26-036), with $100,000 awards for about 40 recipients, and RCORP-Impact (HRSA-26-037), with awards of up to $750,000 for about 80 recipients. Both were due July 8, 2026 and have closed. HRSA's FY2027 forecasts list RCORP Overdose Response, Community Systems Development, and Evaluation notices. To be eligible, your organization must serve a rural area as defined by HRSA's rural health grants eligibility analyzer.

How do opioid settlement funds interact with federal grants?

Opioid litigation settlement funds from lawsuits against pharmaceutical manufacturers and distributors are not federal grants, but they interact with federal opioid funding in several ways. Most settlement agreements require that funds be used for opioid abatement purposes, including treatment, prevention, harm reduction, and recovery services. The national settlements total tens of billions of dollars, paid out over many years on schedules that vary by agreement. States and localities receiving both settlement funds and federal grants like SOR must ensure they're not using settlement money to supplant existing federal or state spending. Smart jurisdictions use settlement funds for activities that federal grants don't cover well, like capital projects, workforce incentives, or populations not eligible for Medicaid-funded treatment.

Last updated October 9, 2026. Corrected October 9, 2026: what changed. Published by Grantsights from public sources. See our editorial policy, how we build and check guides, corrections and how we make money.